COVID-19 and vaccine nationalism: managing the politics of global pandemics, an introduction

Otenyo, Eric E.

doi:10.1016/b978-0-443-18570-0.00005-1

Cited by 2 publications

(2 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The current condition of global health security is facing challenges in the Corona Virus Disease 2019 (COVID-19) pandemic (Rosyanti & Hadi, 2020). The pandemic forces us to quickly adapt to the course of the COVID-19 disease, including providing the COVID-19 vaccine (E. E. Otenyo, 2023). In the exploding number of the vaccination program injection, the vaccine industry also faces growth in adverse events following immunization (AEFI) reports (Hadinegoro, 2016).…”

Section: Introductionmentioning

confidence: 99%

Processing of Individual Case Safety Reports in The Pharmacovigiland Department of Indonesian Vaccine Companies

Irham

Basri

2023

JWS

View full text Add to dashboard Cite

Introduction: This study aimed to determine and analyze the processing design of individual case safety reports in Indonesia's pharmacovigilance department of vaccine companies. Method: This study combines qualitative and quantitative studies that propose implementing the new artificial intelligence system for the PV Department. Result: The results obtained from this study are problem-solving solutions by increasing the number of staff, using artificial intelligence (AI) technology in AEFI case processing to avoid errors and manual input, and approaching external stakeholders to be able to report safety data efficiently and more structured. Conclusion: With the addition of human resources to process the AEFI reporting data by one person, performance value will be increased to 165%. If the process utilizes AI technology, case processing performance increases to 219%. Conclusion: disruption of the performance of the pharmacovigilance department in Indonesian biopharmaceutical companies can be caused by the pandemic disrupting the way KIPI cases are reported, so the solution is the addition of human resources, changes in processes and SOPs, as well as approaches to external stakeholders to streamline case processing.

show abstract

Section: Introductionmentioning

confidence: 99%

Processing of Individual Case Safety Reports in The Pharmacovigiland Department of Indonesian Vaccine Companies

Irham

Basri

2023

JWS

View full text Add to dashboard Cite

show abstract

“…Then, the basic individual right that stands out is the right of self-determination. These basic rights are regulated in Article 1 and Article 7 of the International Covenant on Civil and Political Rights (ICCPR) (Otenyo, 2023). The contents of this article then became the basis and urgency of its formation of informed consent as a fulfillment of legal certainty and legal protection (Sugiarti et al, 2020).…”

Section: Introductionmentioning

confidence: 99%

Use Of Standard Clauses in Transactions Therapeutics Based on Regulation Theory

Carwan,

Lestari

2023

IJSSR

View full text Add to dashboard Cite

The standard informed consent clause is prepared and formed by one of the parties to make it easier for doctors and patients to create a therapeutic agreement. One of the parties designed and developed this standard clause to make it easier for doctors and patients to form a therapeutic contract. However, in practice, it is found that the application of standard clauses prepared in advance by hospitals or doctors is only concerned with signatures and has an impact of dissatisfaction that is detrimental to patients. The research method used is juridical-normative. The results showed that based on the theory of legislation, normatively, the standard clause does not violate the principle of freedom of contract because the standard informed consent clause in the Therapeutic Transaction is a form of the initiative of doctors and hospitals as parties who have more expertise to form the main guidelines for doctors and patients in carrying out health services. In Decision Number 63/Pdt.G/2021/PN Kpn, the use of standardized informed consent clauses in therapeutic agreements provides repressive legal protection in the trial and has a positive influence, namely strengthening informed consent as vital and valid evidence in the problem because it has guided whether medical actions are carried out by the agreed actions, SP, SOP, and patient needs.

show abstract

COVID-19 and vaccine nationalism: managing the politics of global pandemics, an introduction

Cited by 2 publications

References 28 publications

Processing of Individual Case Safety Reports in The Pharmacovigiland Department of Indonesian Vaccine Companies

Processing of Individual Case Safety Reports in The Pharmacovigiland Department of Indonesian Vaccine Companies

Use Of Standard Clauses in Transactions Therapeutics Based on Regulation Theory

Contact Info

Product

Resources

About